6-mercaptopurine: Phase II started

Researchers at the National Institute for Health Research Oxford Biomedical Research Centre began a U.K. Phase II trial to evaluate 75 mg/m 2 oral 6MP daily plus 20 mg/m 2 methotrexate weekly in 65 p...